Arun Gaur

Arun Gaur has extensive experience in the pharmaceutical industry. Arun started their most recent position in 2020 as Vice President at PTC Therapeutics, Inc., where they are responsible for establishing the strategy for analytical methods life cycle management. Prior to that, they were the Executive Director and Head of Global Quality Control at Amicus Therapeutics from 2019 to 2020, overseeing analytical method validation and other quality-related tasks. Arun also served as the Executive Director and Head of R&D QA at Celgene from 2014 to 2018 and as the Director of Product Quality Management at Biogen from 2013 to 2014. Arun Gaur began their career at ImClone Systems in 2001, where they held various roles in quality control and stability management. Arun'swork experience demonstrates a focus on quality assurance and analytical development in the pharmaceutical industry.

Arun Gaur has a Post Doctoral Fellowship from Rutgers University's Center for Advanced Biotechnology and Medicine. Arun also has a Ph.D. in Cellular & Molecular Biology from the State University of New York Upstate Medical University. Additionally, they have an M.Sc. in Microbiology from The Maharaja Sayajirao University of Baroda and a B.Sc. in Microbiology from the University of Mumbai.